Institute of Cellular Therapeutics Allegheny Health Network

Pittsburgh, Pennsylvania 15212

0 studies enrolling now · 1 studies all time

What they study most

Type I Diabetes

Studies at this site

• Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes — Withdrawn before enrolling